Current and historical daily PE Ratio for GeneTether Therapeutics Inc (
) from 2022 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. GeneTether Therapeutics stock (XCNQ:GTTX) PE ratio as of Jun 05 2024 is 0.
More Details
GeneTether Therapeutics Inc (XCNQ:GTTX) PE Ratio (TTM) Chart
GeneTether Therapeutics Inc (XCNQ:GTTX) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 569
- 1
- 2
- 3
- 4
- 5
- 6
- 7
GeneTether Therapeutics PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-05 | At Loss | 2024-04-03 | At Loss |
2024-06-04 | At Loss | 2024-04-02 | At Loss |
2024-06-03 | At Loss | 2024-04-01 | At Loss |
2024-05-31 | At Loss | 2024-03-29 | At Loss |
2024-05-30 | At Loss | 2024-03-28 | At Loss |
2024-05-29 | At Loss | 2024-03-27 | At Loss |
2024-05-28 | At Loss | 2024-03-26 | At Loss |
2024-05-27 | At Loss | 2024-03-25 | At Loss |
2024-05-24 | At Loss | 2024-03-22 | At Loss |
2024-05-23 | At Loss | 2024-03-21 | At Loss |
2024-05-22 | At Loss | 2024-03-20 | At Loss |
2024-05-21 | At Loss | 2024-03-19 | At Loss |
2024-05-20 | At Loss | 2024-03-18 | At Loss |
2024-05-17 | At Loss | 2024-03-15 | At Loss |
2024-05-16 | At Loss | 2024-03-14 | At Loss |
2024-05-15 | At Loss | 2024-03-13 | At Loss |
2024-05-14 | At Loss | 2024-03-12 | At Loss |
2024-05-13 | At Loss | 2024-03-11 | At Loss |
2024-05-10 | At Loss | 2024-03-08 | At Loss |
2024-05-09 | At Loss | 2024-03-07 | At Loss |
2024-05-08 | At Loss | 2024-03-06 | At Loss |
2024-05-07 | At Loss | 2024-03-05 | At Loss |
2024-05-06 | At Loss | 2024-03-04 | At Loss |
2024-05-03 | At Loss | 2024-03-01 | At Loss |
2024-05-02 | At Loss | 2024-02-29 | At Loss |
2024-05-01 | At Loss | 2024-02-28 | At Loss |
2024-04-30 | At Loss | 2024-02-27 | At Loss |
2024-04-29 | At Loss | 2024-02-26 | At Loss |
2024-04-26 | At Loss | 2024-02-23 | At Loss |
2024-04-25 | At Loss | 2024-02-22 | At Loss |
2024-04-24 | At Loss | 2024-02-21 | At Loss |
2024-04-23 | At Loss | 2024-02-20 | At Loss |
2024-04-22 | At Loss | 2024-02-19 | At Loss |
2024-04-19 | At Loss | 2024-02-16 | At Loss |
2024-04-18 | At Loss | 2024-02-15 | At Loss |
2024-04-17 | At Loss | 2024-02-14 | At Loss |
2024-04-16 | At Loss | 2024-02-13 | At Loss |
2024-04-15 | At Loss | 2024-02-12 | At Loss |
2024-04-12 | At Loss | 2024-02-09 | At Loss |
2024-04-11 | At Loss | 2024-02-08 | At Loss |
2024-04-10 | At Loss | 2024-02-07 | At Loss |
2024-04-09 | At Loss | 2024-02-06 | At Loss |
2024-04-08 | At Loss | 2024-02-05 | At Loss |
2024-04-05 | At Loss | 2024-02-02 | At Loss |
2024-04-04 | At Loss | 2024-02-01 | At Loss |
GeneTether Therapeutics Inc (XCNQ:GTTX) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
GeneTether Therapeutics Inc
NAICS : 325412
SIC : 3741
ISIN : CA37187D1087
Description